Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Oral Lansoprazole PD in Erosive Esophagitis
NCT00175045Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2003
- Primary completion
- Oct 2003
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of lansoprazole in erosive esophagitis (EE), sponsored by Takeda. Primary endpoint: Maximal Acid Output at Day 15. Started Jun 2003; status: completed.
02
Drugs
lansoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT00175045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175045.